Levine M, Adida B, Mandl K, Kohane I, Halamka J (2007) What are the benefits and risks of fitting patients with radiofrequency identification devices? PLoS Med 4(11): e322. doi:10.1371/journal.pmed.0040322
John Halamka declared that he had no competing interests. While he has no financial relationship with the VeriChip Corporation, he serves as an unpaid adviser to the corporation on privacy, security, and standards issues, as well as strategy and future applications of the VeriChip radiofrequency identification implantable microchip technology.
Citation: Levine M, Adida B, Mandl K, Kohane I, Halamka J (2008) Correction: What Are the Benefits and Risks of Fitting Patients with Radiofrequency Identification Devices? PLoS Med 5(2): e36. https://doi.org/10.1371/journal.pmed.0050036
Received: December 17, 2007; Accepted: December 17, 2007; Published: February 5, 2008
Copyright: © 2008 Levine et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.